Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations

Journal of Infectious Diseases

Volumn 181, Issue 1, 2000, Pages 42-50

  Gordon, Ethel J ^a,e   Bhat, Ramesh ^c   Liu, Qingyan ^a   Wang, Yun Fen ^b   Tackney, Charles ^d   Prince, Alfred M ^a  

^a L F K R I of the NY B C   (United States)

^b BRONX LEBANON HOSPITAL CENTER   (United States)

^c WYETH AYERST RESEARCH   (United States)

^d Ortho McNeil Pharmaceutical Incorporated   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PLASMID DNA; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; HEPATITIS C VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS CAPSID;

ANIMALS; ANTIBODY SPECIFICITY; BASE SEQUENCE; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; IMMUNITY, CELLULAR; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLASMIDS; VACCINATION; VACCINES, DNA; VIRAL HEPATITIS VACCINES; VIRAL NONSTRUCTURAL PROTEINS; VIRAL STRUCTURAL PROTEINS;

EID: 0033958695     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315162     Document Type: Article

References (39)

1. 1. Cha TA, Beall E, Irvine B, et al. At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci USA 1992;89:7144-8.
2. 2. Okada S, Akahene Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein if the hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 1992;16:619-24.
3. 3. Okamoto H, Kojima M, Okada SI, et al. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 1992;190:894-9.
4. 4. Tanaka T, Kato N, Nakagawa M, et al. Molecular cloning of hepatitis virus genome from a single Japanese carrier: sequence variation within the same individual and among infected individuals. Virus Res 1992;23:39-53.
5. 5. Thomssen R, Bonks S, Propfe C, Heermann KH, Kochel HG, Uy A. Association of hepatitis C virus in human sera with α-lipoprotein. Med Microbiol Immunol 1992;181:293-300.
6. 6. Prince AM, Huima-Byron T, Parker TS, Levin DM. Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins. J Viral Hepat 1996;3:11-7.
7. 7. Prince AM, Brotman B, Huima T, Pascual D, Jaffery M, Inchauspe G. Immunity in hepatitis C infection. J Infect Dis 1992;165:438-43.
8. 8. Saito T, Sherman GJ, Kurokohchi K, et al. Plasmid DNA-based immunization for hepatitis C virus structural proteins: immune response in mice. Gastroenterology 1997;112:1321-30.
9. 9. Shirai M, Akatsuka T, Pendleton CD, et al. Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. J Virol 1992;66:4098-106.
10. 10. Inchauspé G, Major ME, Nakano I, Vitvitski L, Trépo C. DNA vaccination for the induction of immune responses against hepatitis C virus proteins. Vaccine 1997;15:853-6.
11. 11. Tokushige K, Wakita T, Pachuk C, et al. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology 1996;24:14-20.
12. 12. Lagging LM, Meyer K, Hoft D, Houghton M, Belshie RB, Ray R. Immune response to hepatitis C virus core protein. J Virol 1995;69:5859-63.
13. 13. Major ME, Vitvitski L, Mink MA, et al. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J Virol 1995;69:5798-805.
14. 14. Nakano I, Maertens G, Major ME, et al. Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode. J Virol 1997;71:7101-9.
15. 15. Inchauspé G, Vitvitski L, Major ME, et al. Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol 1997;16:185-95.
16. 16. Geissler M, Gesien A, Tokushige K, Wands JR. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol 1997;158:1231-7.
17. 17. Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465-8.
18. 18. Tang DC, McDeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992;365:152-4.
19. 19. Pardoll DM, Beckerleg AM. Exposing the immunology of naked DNA vaccines. Immunity 1995;3:165-9.
20. 20. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
21. 21. Kato N, Hijikata M, Ootsuyama Y, et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990;87:9524-8.
22. 22. Takamizawa A, Mori C, Fuke I, et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 1991;65: 1105-13.
23. 23. Kozak M. Structural features in eukaryotic mRNAs that modulate the initiation of translation. J Biol Chem 1991;266:19867-70.
24. 24. Liu QY. Tackney C, Bhat R, Prince AM, Zhang P. Regulated processing of hepatitis C virus core protein is linked to subcellular localization. J Virol 1997;71:657-62.
25. 25. Davis HL, Demeneix BA, Quantin B, Coulombe J, Whalen RG. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum Gene Ther 1993;4:151-9.
26. 26. Raz E, Carson DA, Parker SE, et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 1994;91:9519-23.
27. 27. Shirai M, Arichi T, Nishioka M, et al. CTL responses of HLA-A2.1 transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J Immunol 1995;154:2733-42.
28. 28. Walker C, Selby M, Erickson A, Cataldo D, Valensi JP, Van Nest G. Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway. Proc Natl Acad Sci USA 1992; 89:7915-8.
29. 29. Davis HL, Michel ML, Whalen RG. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet 1993;2:1847-51.
30. 30. Tanaka T, Kato N, Cho MJ, Sugiyama K, Shimotohno K. Structure of the 3′ terminus of the hepatitis C virus genome. J Virol 1996;70:3307-12.
31. 31. Encke J, zu Putlitz J, Geissler M, Wands JR. Genetic immunization generates cellular and humoral immune responses against nonstructural proteins of the hepatitis C virus in a murine model. J Immunol 1998;161:4917-23.
32. 32. Falk K, Rötzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991;351:290-6.
33. 33. Rammensee HG, Friede T, Stevanovic S. MHC ligands and peptides motifs: first listing. Immunogenetics 1995;41:178-228.
34. 34. Cornette JL, Margalit H, Berzofsky JA, DeLisi C. Periodic variation in sidechain polarities of T-cell antigenic peptides correlates with their structure and activity. Proc Natl Acad Sci USA 1995;92:8368-72.
35. 35. Oldstone MBA, Lewicki H, Borrow P, Hudrisier D, Gairin JE. Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection. J Virol 1995;69:7423-9.
36. 36. Kurokohchi K, Akatsuka T, Pendleton CD, et al. Use of recombinant protein to identify motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region. J Virol 1996;70:232-40.
37. 37. Hofland HEJ, Shepard L, Sullivan SM. Formation of stable cationic lipid/ DNA complexes for gene transfer. Proc Natl Acad Sci USA 1996;93: 7305-9.
38. 38. Willems L, Portetelle D, Kerkhofs P, et al. In vivo transfection of bovine leukemia provirus into sheep. Virology 1992;189:775-7.
39. 39. Cohard M, Liu Q, Perkus M, Gordon E, Brotman B, Prince AM. Hepatitis C virus-specific CTL responses in PBMC from chimpanzees with chronic hepatitis C: determination of CTL and CTL precursor frequencies using a recombinant canarypox virus (ALVAC). J Immunol Methods 1998;214: 121-9.